Latest 10-K annual reports

NYSE
RPM Funding Corporation and its Originators have entered into Amendment No. 14 to their Second Amended and Restated Receivables Sale Agreement, effective May 27, 2026.
OQB
Star Gold Corp. files its annual report for the fiscal year ended April 30, 2026, detailing progress on the Longstreet Property, financial performance, and operational plans.
OTC.Pink
NaturalShrimp Incorporated has filed its annual report, detailing its transition to a liquidation basis of accounting following a receivership and asset sale, and outlining a new intellectual property and management transition agreement.
NASDAQ
Cal-Maine Foods announced a substantial decrease in net income for fiscal year 2026, primarily driven by a significant drop in conventional shell egg prices.
AMEX
Starfighters Space, Inc. files Amendment No. 1 to its 2025 10-K to enhance disclosures on segment reporting, property, and error corrections.
NYSE
FedEx Corporation announced its fiscal year 2026 results, highlighting revenue growth and improved operating income driven by yield improvements and cost-saving initiatives.
NASDAQ
MillerKnoll announced its fiscal year 2026 results, showing a 4.7% increase in net sales to $3.84 billion, driven by volume growth and pricing actions.
OTC.Pink
Bakhu Holdings Corp. files its Form 10-K for the fiscal year ended July 31, 2024, detailing significant financial challenges, ongoing efforts to secure funding, and operational suspensions.
OTC.Pink
Jingbo Technology, Inc. (Jingbo) filed its annual report for the fiscal year ended February 28, 2026, detailing a net loss of $6.7 million and highlighting substantial doubt about its ability to continue as a going concern.
NASDAQ
Paychex, Inc. announced its fiscal year 2026 results, showcasing a 17% increase in total revenue to $6.5 billion, largely attributed to the acquisition of Paycor and continued growth in its human capital management solutions.
Sonnet Biotherapeutics Holdings, Inc. files an amended annual report (10-K/A) for the fiscal year ended September 30, 2025, primarily to correct the auditor's report.
NASDAQ
Culp, Inc. reported a net loss of $10.2 million for fiscal year 2026, an improvement from the previous year, with net sales down 4.6%.
OQB
Zoomcar Holdings, Inc. is filing an amendment to its Form 10-K for the fiscal year ended March 31, 2026, to correct administrative errors and present the report as approved by the company.
NASDAQ
New Horizon Aircraft Ltd. outlines its progress in developing the Cavorite X7 hybrid-electric eVTOL aircraft, detailing its technology, market strategy, and financial status.
OID
Caro Holdings Inc. reports on its fiscal year ended March 31, 2026, detailing its shift to B2B/B2C/D2C digital solutions, a spirits marketplace acquisition, and a new mining property interest, while continuing to operate at a net loss.
NYSE
NIKE, Inc. announced its fiscal year 2026 results, reporting flat revenues of $46.4 billion and a slight increase in gross margin to 42.9%.
NYSE
Conagra Brands, Inc. filed its annual report for the fiscal year ended May 31, 2026, detailing financial performance, strategic initiatives, and risk factors.
OQB
Zoomcar Holdings, Inc. (ZCAR) filed its Form 10-K for the fiscal year ended March 31, 2026, detailing a complex financial situation marked by ongoing efforts to secure funding, manage debt obligations, and address litigation.
OID
Antiaging Quantum Living Inc. files its annual 10-K report, detailing a strategic shift towards proprietary health products and therapy services, alongside financial performance and operational updates.
OQB
Biotricity Inc. announced its fiscal year 2026 results, showing revenue growth and a reduced net loss, while highlighting ongoing product development and market expansion.
NASDAQ
Americas Car-Mart reports significant net loss for fiscal year 2026, driven by reduced operations and ongoing liquidity challenges, while detailing efforts to stabilize finances and explore strategic alternatives.
OQB
Nordicus Partners Corporation files its annual report for the fiscal year ended March 31, 2026, detailing its preclinical biotech developments, acquisitions, and financial performance.
NASDAQ
Kestra Medical Technologies, Ltd. announced a 59% increase in revenue for the fiscal year ended April 30, 2026, driven by a significant rise in patient adoption of its ASSURE WCD.
OID
Yinfu Gold Corporation filed its annual report on Form 10-K for the fiscal year ended March 31, 2026, detailing its financial condition, operational status, and risk factors.
OTC.Pink
Waste Energy Corp. details its strategic pivot to waste-to-energy operations, including progress on its Midland, Texas facility and ongoing financial challenges.
VivoSim Labs, Inc. (VIVS) has transitioned from a clinical-stage biotechnology company to a pharmaceutical and biotechnology services provider focused on 3D human tissue models for drug testing.
NYSE
Permian Basin Royalty Trust files an amended annual report for the fiscal year ended December 31, 2025, to update disclosures regarding properties, financial condition, and oil and gas reserve information.
OQB
King Resources, Inc. has transitioned its primary business to arts and collectibles, reporting significant revenue growth but a net loss for fiscal year 2026.
NASDAQ
AngioDynamics, Inc. announced its fiscal year 2026 results, highlighting a 9.5% increase in net sales driven by its Med Tech segment, while navigating a net loss and implementing strategic restructuring initiatives.
OTC.Pink
Ranger Gold Corp. files its annual 10-K report, detailing its strategy to acquire and develop natural resource properties, primarily gold, while currently having no operational assets or revenue.